Fabrication of antibacterial carbonate apatite bone cement starting from vaterite, monetite and disodium hydrogenphosphate with gentamicin sulfate
Source abstract
Abstract
The present article describes the fabrication of a bioresorbable, antibacterial bone cement comprising carbonate apatite (CO3Ap) and gentamicin sulfate (GNT). We focused on a fast-setting CO3Ap cement using vaterite and monetite as raw powders and Na2HPO4 as a mixing solution, to which we added GNT. The initial setting time, physical properties, drug release property, antibacterial property, and in vivo bioresorbability and biocompatibility of the CO3Ap cements were evaluated. The addition of GNT decreased the initial setting time without affecting the other physical properties of the set cements. Moreover, the GNT-loaded CO3Ap cements demonstrated potential for drug sustained-release and prevented the growth of Escherichia coli. In vivo studies, the cement formed osteoconductive connections with the bone-like tissues in rat tibia; however, delayed bioresorption was observed. Based on these results, we conclude that GNT-loaded CO3Ap cements that reduce the risk of surgical site infection are potential candidates for bioabsorbable bone cement.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Calcium Carbonate Crystallization and Inhibition · Bone Tissue Engineering Materials · Microbial Applications in Construction Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Section of Bioengineering, Department of Dental Engineering, Fukuoka Dental College
Section of Orthodontics, Department of Oral Growth and Development, Fukuoka Dental College
Section of Biomaterials, Department of Dental Engineering, Fukuoka Dental College
Department of Liberal Arts and Sciences, College of Science and Technology, Nihon University
References (35)
Show source-provided references
1. 1) Zhao C, Liu W, Zhu M, Wu C, Zhu Y. Bioceramic-based scaffolds with antibacterial function for bone tissue engineering: A review. Bioact Mater 2022; 18: 383-398.10.1016/j.bioactmat.2022.02.010 ↗
2. 2) Unnithan AR, Arathyram RS, Kim CS. In: Thomas S, Grohens Y, Ninan N. editors. Nanotechnology Applications for Tissue Engineering. Oxford, William Andrew Publishing. 2015. p. 103-123.10.1016/B978-0-323-32889-0.00007-8 ↗
3. 3) Vallet-Reg M, Lozano D, Gonzalez B, Izquierdo-Barba I. Biomaterials against bone infection. Adv Healthc Mater 2020; 9: 2000310.10.1002/adhm.202000310 ↗
4. 4) Ishikawa K. Bone substitute fabrication based on dissolution- precipitation reactions. Materials 2010; 3: 1138-1155.10.3390/ma3021138 ↗
5. 5) Ayukawa Y, Suzuki Y, Tsuru K, Koyano K, Ishikawa K. Histological comparison in rats between carbonate apatite fabricated from gypsum and sintered hydroxyapatite on bone remodeling. Biomed Res Int 2015; 2015: 579541.10.1155/2015/579541 ↗
6. 6) Khairoun I, Boltong MG, Driessens FCM, Planell JA. Effect of calcium carbonate on clinical compliance of apatitic calcium phosphate bone cement. J Biomed Mater Res 1997; 38: 356-360.10.1002/(SICI)1097-4636(199724)38:4<356::AID-JBM8>3.0.CO;2-N ↗
7. 7) Ooms EM, Egglezos EA, Wolke JGC, Jansen JA. Soft-tissue response to injectable calcium phosphate cements. Biomaterials 2003; 24: 749-757.10.1016/S0142-9612(02)00408-8 ↗
8. 8) Takagi S, Chow LC, Ishikawa K. Formation of hydroxyapatite in new calcium phosphate cements. Biomaterials 1998; 19: 1593-1599.10.1016/S0142-9612(97)00119-1 ↗
9. 9) Daitou F, Maruta M, Kawachi G, Tsuru K, Matsuya S, Terada Y, et al. Fabrication of carbonate apatite block based on internal dissolution-precipitation reaction of dicalcium phosphate and calcium carbonate. Dent Mater J 2010; 29: 303-308.10.4012/dmj.2009-095 ↗
10. 10) Plummer LN, Busenberg E. The solubilities of calcite, aragonite and vaterite in CO2-H2O solutions 0 and 90°C, and an evaluation of the aqueous model for the system CaCO3-CO2-H2O. Geochem Cosmochim Acta 1982; 46: 1011-1040.10.1016/0016-7037(82)90056-4 ↗
11. 11) Combes C, Bareille R, Rey C. Calcium carbonate-calcium phosphate mixed cement compositions for bone reconstruction. J Biomed Mater Res 2006; 79A: 318-328.10.1002/jbm.a.30795 ↗
12. 12) Cahyanto A, Maruta M, Tsuru K, Matsuya S, Ishikawa K. Fabrication of bone cement that fully transforms to carbonate apatite. Dent Mater J 2015; 34: 394-401.10.4012/dmj.2014-328 ↗
13. 13) Kumar Dewangan V, Sampath Kumar TS, Doble M, Daniel Varghese V. Fabrication of injectable antibiotic-loaded apatitic bone cements with prolonged drug delivery for treating post-surgery infections. J Biomed Mater Res A 2023; 111: 1750-1767.10.1002/jbm.a.37584 ↗
14. 14) Oshima S, Sato T, Honda M, Suetsugu Y, Ozeki K, Kikuchi M. Fabrication of gentamicin-loaded hydroxyapatite/collagen bone-like nanocomposite for anti-infection bone void fillers. Int J Mol Sci 2020; 21: 551.10.3390/ijms21020551 ↗
15. 15) Gimeno M, Pinczowski P, Pérez M, Giorello A, Martínez MÁ, Santamaría J, et al. A controlled antibiotic release system to prevent orthopedic-implant associated infections: An in vitro study. Eur J Pharm Biopharm 2015; 96: 264-271.10.1016/j.ejpb.2015.08.007 ↗
16. 16) Guo YJ, Long T, Chen W, Ning CQ, Zhu ZA, Guo YP. Bactericidal property and biocompatibility of gentamicin-loaded mesoporous carbonated hydroxyapatite microspheres. Mater Sci Eng C 2013; 33: 3583-3591.10.1016/j.msec.2013.04.021 ↗
17. 17) Sasaki K, Ninomiya Y, Takechi M, Tsuru K, Ishikawa K, Shigeishi H, et al. Physical properties and antimicrobial release ability of gentamicin-loaded apatite cement/α-TCP composites: An in vitro study. Materials 2023; 16: 995.10.3390/ma16030995 ↗
18. 18) Haine ER, Pollitt LC, Moret Y, Siva-Jothy MT, Rolff J. Temporal patterns in immune responses to a range of microbial insults (Tenebrio molitor). J Insect Physiol 2008; 54: 1090-1097.10.1016/j.jinsphys.2008.04.013 ↗
19. 19) Grigoraviciute-Puroniene I, Tanaka Y, Vegelyte V, Nishimoto Y, Ishikawa K, Kareiva A. A novel synthetic approach to low-crystallinity calcium deficient hydroxyapatite. Ceram Int 2019; 45: 15620-15623.10.1016/j.ceramint.2019.05.072 ↗
20. 20) Garskaite E, Gross KA, Yang SW, Yang TCK, Yang JC, Kareiva A. Effect of processing conditions on the crystallinity and structure of carbonated calcium hydroxyapatite (CHAp). Cryst Eng Comm 2014; 16: 3950-3959.10.1039/c4ce00119b ↗
21. 21) Abdel-Fattah WI, Reicha FM, Elkhooly TA. Nano-beta-tricalcium phosphates synthesis and biodegradation: 1. Effect of microwave and SO42− ions on β-TCP synthesis and its characterization. Biomed Mater 2008; 3: 034121.10.1088/1748-6041/3/3/034121 ↗
22. 22) Sinusaite L, Grigoraviciute-Puroniene I, Popov A, Ishikawa K, Kareiva A, Zarkov A. Controllable synthesis of tricalcium phosphate (TCP) polymorphs by wet precipitation: Effect of washing procedure. Ceram Int 2019; 45: 12423-12428.10.1016/j.ceramint.2019.03.174 ↗
23. 23) Leventouri T, Bunaciu CE, Perdikatsis V. Neutron powder diffraction studies of silicon-substituted hydroxyapatite. Biomaterials 2003; 24: 4205-4211.10.1016/S0142-9612(03)00333-8 ↗
24. 24) Monma H, Nemoto O, Takahashi S, Kobayashi H. Electrolytic formation and morphology of biomimetic apatite coatings. J Electroceram 1999; 4: 135-140.10.1023/A:1009975129238 ↗
25. 25) Lafon JP, Champion E, Bernache-Assollant D. Processing of AB-type carbonated hydroxyapatite Ca10−x(PO4)6−x(CO3)x(OH)2−x−2y(CO3)y ceramics with controlled composition. J Eur Ceram Soc 2008; 28: 139-147.10.1016/j.jeurceramsoc.2007.06.009 ↗
26. 26) Ishikawa K, Matsuya S. In: Milne I, Ritchie RO, Karihaloo B, editors. Comprehensive structural integrity. Oxford, Elsevier. 2003. p. 169-214.10.1016/B0-08-043749-4/09146-1 ↗
27. 27) De Visscher A, Vanderdeelen J. Estimation of the solubility constant of calcite, aragonite, and vaterite at 25°C based on primary data using the pitzer ion interaction approach. Mon Chem 2003; 134: 769-775.10.1007/s00706-002-0587-3 ↗
28. 28) Cahyanto A, Maruta M, Tsuru K, Matsuya S, Ishikawa K. Basic properties of carbonate apatite cement consisting of vaterite and dicalcium phosphate anhydrous. Key Eng Mater 2013; 529-530: 192-196.10.4028/www.scientific.net/KEM.529-530.192 ↗
29. 29) Gal JY, Bollinger JC, Tolosa H, Gache N. Calcium carbonate solubility: A reappraisal of scale formation and inhibition. Talanta 1996; 43: 1497-1509.10.1016/0039-9140(96)01925-X ↗
30. 30) Elliott JC, Holcomb DW, Young RA. Infrared determination of the degree of substitution of hydroxyl by carbonate ions in human dental enamel. Calcif Tissue Int 1985; 37: 372-375.10.1007/BF02553704 ↗
31. 31) Sato T, Maruta M, Minamisawa H, Kajimoto N, Tsuru K. Carbonate content regulation of the set carbonate apatite cement starting from vaterite and monetite by using various sodium phosphate solutions. Ceram Int 2025; 51: 6654-6659.10.1016/j.ceramint.2024.12.109 ↗
32. 32) Geuli O, Metoki N, Zada T, Reches M, Eliaz N, Mandler D. Synthesis, coating, and drug-release of hydroxyapatite nanoparticles loaded with antibiotics. J Mater Chem B 2017; 5 :7819-7830.10.1039/C7TB02105D ↗
33. 33) Stevanović M, Djošić M, Janković A, Kojić V, Vukašinović-Sekulić M, Stojanović J, et al. Antibacterial graphene-based hydroxyapatite/chitosan coating with gentamicin for potential applications in bone tissue engineering. J Biomed Mater Res A 2020; 108: 2175-2189.10.1002/jbm.a.36974 ↗
34. 34) Van de Belt H, Neut D, Uges DRA, Schenk W, Van Horn JR, Van der Mei HC, et al. Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic release. Biomaterials 2000; 21: 1981-1987.10.1016/S0142-9612(00)00082-X ↗
35. 35) Coimbra P, Freitas JP, Gonçalves T, Gil MA, Figueiredo M. Preparation of gentamicin sulfate eluting fiber mats by emulsion and by suspension electrospinning. Mater Sci Eng C 2019; 94: 86-93.10.1016/j.msec.2018.09.019 ↗